Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1286

1.

Intravenous Tissue Plasminogen Activator in Stroke Mimics.

Ali-Ahmed F, Federspiel JJ, Liang L, Xu H, Sevilis T, Hernandez AF, Kosinski AS, Prvu Bettger J, Smith EE, Bhatt DL, Schwamm LH, Fonarow GC, Peterson ED, Xian Y.

Circ Cardiovasc Qual Outcomes. 2019 Aug;12(8):e005609. doi: 10.1161/CIRCOUTCOMES.119.005609. Epub 2019 Aug 15.

PMID:
31412730
2.

The Changing Landscape of Aortic Valve Replacement in the United States.

Gupta T, Kolte D, Khera S, Goel K, Villablanca PA, Kalra A, Abbott JD, Elmariah S, Fonarow GC, Rihal CS, Garcia MJ, Weisz G, Bhatt DL.

EuroIntervention. 2019 Aug 13. pii: EIJ-D-19-00381. doi: 10.4244/EIJ-D-19-00381. [Epub ahead of print]

3.

Early Effects of Starting Doses of Enalapril in Patients with Chronic Heart Failure in the SOLVD Treatment Trial.

Lam PH, Packer M, Fonarow GC, Faselis C, Allman RM, Morgan CJ, Singh S, Pitt B, Ahmed A.

Am J Med. 2019 Aug 8. pii: S0002-9343(19)30615-1. doi: 10.1016/j.amjmed.2019.06.053. [Epub ahead of print]

PMID:
31401165
4.

Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.

Malik A, Masson R, Singh S, Wu WC, Packer M, Pitt B, Waagstein F, Morgan CJ, Allman RM, Fonarow GC, Ahmed A.

J Am Coll Cardiol. 2019 Aug 6;74(5):617-627. doi: 10.1016/j.jacc.2019.05.064.

PMID:
31370952
5.

Body mass index and outcomes of cardiac resynchronization with implantable cardioverter-defibrillator therapy in older patients with heart failure.

Echouffo-Tcheugui JB, Masoudi FA, Bao H, Curtis JP, Heidenreich PA, Fonarow GC.

Eur J Heart Fail. 2019 Jul 29. doi: 10.1002/ejhf.1552. [Epub ahead of print]

PMID:
31359595
6.

Regional Differences in Secondary Prevention Therapy-Geography Should Not Be Destiny.

Navar AM, Fonarow GC.

JAMA Cardiol. 2019 Jul 24. doi: 10.1001/jamacardio.2019.2548. [Epub ahead of print] No abstract available.

PMID:
31339523
7.

Prior Heart Failure Hospitalization and Outcomes in Patients with Heart Failure with Preserved and Reduced Ejection Fraction.

Malik A, Gill GS, Lodhi FK, Tummala LS, Singh SN, Morgan CJ, Allman RM, Fonarow GC, Ahmed A.

Am J Med. 2019 Jul 20. pii: S0002-9343(19)30581-9. doi: 10.1016/j.amjmed.2019.06.040. [Epub ahead of print]

PMID:
31336093
8.

Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke: Findings From the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study.

Xian Y, Xu H, O'Brien EC, Shah S, Thomas L, Pencina MJ, Fonarow GC, Olson DM, Schwamm LH, Bhatt DL, Smith EE, Hannah D, Maisch L, Lytle BL, Peterson ED, Hernandez AF.

JAMA Neurol. 2019 Jul 22. doi: 10.1001/jamaneurol.2019.2099. [Epub ahead of print]

PMID:
31329212
9.

Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy.

Inohara T, Liang L, Kosinski AS, Smith EE, Schwamm LH, Hernandez AF, Bhatt DL, Fonarow GC, Peterson ED, Xian Y.

J Am Heart Assoc. 2019 Aug 6;8(15):e012450. doi: 10.1161/JAHA.119.012450. Epub 2019 Jul 20.

10.

Hospital distance, socioeconomic status, and timely treatment of ischemic stroke.

Ader J, Wu J, Fonarow GC, Smith EE, Shah S, Xian Y, Bhatt DL, Schwamm LH, Reeves MJ, Matsouaka RA, Sheth KN.

Neurology. 2019 Aug 20;93(8):e747-e757. doi: 10.1212/WNL.0000000000007963. Epub 2019 Jul 18.

PMID:
31320472
11.

Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice.

Jahan R, Saver JL, Schwamm LH, Fonarow GC, Liang L, Matsouaka RA, Xian Y, Holmes DN, Peterson ED, Yavagal D, Smith EE.

JAMA. 2019 Jul 16;322(3):252-263. doi: 10.1001/jama.2019.8286.

PMID:
31310296
12.

Impediments to Implementing Guideline-Directed Medical Therapies.

Fonarow GC, Navar AM, Yancy CW.

JAMA Cardiol. 2019 Jul 10. doi: 10.1001/jamacardio.2019.2276. [Epub ahead of print] No abstract available.

PMID:
31290930
13.

Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.

Pokorney SD, Holmes DN, Thomas L, Fonarow GC, Kowey PR, Reiffel JA, Singer DE, Freeman JV, Gersh BJ, Mahaffey KW, Hylek EM, Naccarelli GV, Ezekowitz MD, Piccini JP, Peterson ED; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators.

JAMA Cardiol. 2019 Jul 3. doi: 10.1001/jamacardio.2019.1960. [Epub ahead of print]

14.

Aberrant Brain Functional Connectivity Dynamic Responses to the Valsalva Maneuver in Heart Failure.

Song X, Roy B, Lai M, Sahib A, Fonarow GC, Woo MA, Kumar R.

J Card Fail. 2019 Jun 29. pii: S1071-9164(18)31069-8. doi: 10.1016/j.cardfail.2019.06.010. [Epub ahead of print]

PMID:
31265919
15.

Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.

Arundel C, Lam PH, Gill GS, Patel S, Panjrath G, Faselis C, White M, Morgan CJ, Allman RM, Aronow WS, Singh SN, Fonarow GC, Ahmed A.

J Am Coll Cardiol. 2019 Jun 25;73(24):3054-3063. doi: 10.1016/j.jacc.2019.04.022.

PMID:
31221253
16.

Physicians Voluntarily Using an EHR-Based CDS Tool Improved Patients' Guideline-Related Statin Prescription Rates: A Retrospective Cohort Study.

Chang TS, Buchipudi A, Fonarow GC, Pfeffer MA, Singer JS, Cheng EM.

Appl Clin Inform. 2019 May;10(3):421-445. doi: 10.1055/s-0039-1692186. Epub 2019 Jun 19.

PMID:
31216590
17.

Cohort Study of Repeated Measurements of Serum Urate and Risk of Incident Atrial Fibrillation.

Li S, Cheng J, Cui L, Gurol ME, Bhatt DL, Fonarow GC, Benjamin EJ, Xing A, Xia Y, Wu S, Gao X.

J Am Heart Assoc. 2019 Jul 2;8(13):e012020. doi: 10.1161/JAHA.119.012020. Epub 2019 Jun 19.

18.

The Burden of Congestion in Patients Hospitalized With Acute Decompensated Heart Failure.

Cooper LB, Lippmann SJ, DiBello JR, Gorsh B, Curtis LH, Sikirica V, Hernandez AF, Sprecher DL, Laskey WK, Saini R, Fonarow GC, Hammill BG.

Am J Cardiol. 2019 Aug 15;124(4):545-553. doi: 10.1016/j.amjcard.2019.05.030. Epub 2019 May 25.

PMID:
31208702
19.

Association of Changes in Heart Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF.

Thomas M, Khariton Y, Fonarow GC, Arnold SV, Hill L, Nassif ME, Sharma PP, Butler J, Thomas L, Duffy CI, DeVore AD, Hernandez A, Albert NM, Patterson JH, Williams FB, McCague K, Spertus JA.

JACC Heart Fail. 2019 Jul;7(7):615-625. doi: 10.1016/j.jchf.2019.03.020. Epub 2019 Jun 5.

PMID:
31176672
20.

Updated Cost-effectiveness Analysis of Evolocumab in Patients With Very High-risk Atherosclerotic Cardiovascular Disease.

Fonarow GC, van Hout B, Villa G, Arellano J, Lindgren P.

JAMA Cardiol. 2019 Jul 1;4(7):691-695. doi: 10.1001/jamacardio.2019.1647.

21.

Digoxin Use and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.

Qamer SZ, Malik A, Bayoumi E, Lam PH, Singh S, Packer M, Kanonidis IE, Morgan CJ, Abdelmawgoud A, Allman RM, Fonarow GC, Ahmed A.

Am J Med. 2019 May 29. pii: S0002-9343(19)30443-7. doi: 10.1016/j.amjmed.2019.05.012. [Epub ahead of print]

PMID:
31150644
22.

Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II.

Inohara T, Shrader P, Pieper K, Blanco RG, Allen LA, Fonarow GC, Gersh BJ, Go AS, Ezekowitz MD, Kowey PR, Reiffel JA, Naccarelli GV, Chan PS, Mahaffey KW, Singer DE, Freeman JV, Steinberg BA, Peterson ED, Piccini JP; ORBIT AF Patients and Investigators.

Am Heart J. 2019 Jul;213:81-90. doi: 10.1016/j.ahj.2019.04.007. Epub 2019 Apr 24.

PMID:
31129441
23.

Longitudinal Trajectories of Hospital Performance across Targeted Cardiovascular Conditions in the United States.

Vaduganathan M, McCarthy CP, Ayers C, Bhatt DL, Kumbhani DJ, de Lemos JA, Fonarow GC, Pandey A.

Eur Heart J Qual Care Clin Outcomes. 2019 May 24. pii: qcz026. doi: 10.1093/ehjqcco/qcz026. [Epub ahead of print]

PMID:
31124567
24.

A paradoxical relationship between hemoglobin A1C and in-hospital mortality in intracerebral hemorrhage patients.

Dandapat S, Siddiqui FM, Fonarow GC, Bhatt DL, Xu H, Matsouaka R, Heidenreich PA, Xian Y, Schwamm LH, Smith EE.

Heliyon. 2019 May 6;5(5):e01659. doi: 10.1016/j.heliyon.2019.e01659. eCollection 2019 May.

25.

Thrombolysis in young adults with stroke: Findings from Get With The Guidelines-Stroke.

Dodds JA, Xian Y, Sheng S, Fonarow GC, Bhatt DL, Matsouaka R, Schwamm LH, Peterson ED, Smith EE.

Neurology. 2019 Jun 11;92(24):e2784-e2792. doi: 10.1212/WNL.0000000000007653. Epub 2019 May 15.

PMID:
31092622
26.

Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life Score.

Holmes DN, Piccini JP, Allen LA, Fonarow GC, Gersh BJ, Kowey PR, O'Brien EC, Reiffel JA, Naccarelli GV, Ezekowitz MD, Chan PS, Singer DE, Spertus JA, Peterson ED, Thomas L.

Circ Cardiovasc Qual Outcomes. 2019 May;12(5):e005358. doi: 10.1161/CIRCOUTCOMES.118.005358.

PMID:
31092022
27.

Cardiogenic shock during heart failure hospitalizations: Age-, sex-, and race-stratified trends in incidence and outcomes.

Yandrapalli S, Sanaani A, Harikrishnan P, Aronow WS, Frishman WH, Lanier GM, Ahmed A, Fonarow GC.

Am Heart J. 2019 Jul;213:18-29. doi: 10.1016/j.ahj.2019.03.015. Epub 2019 Apr 11.

PMID:
31078113
28.

Overcoming Barriers to Development of Novel Therapies for Cardiovascular Disease: Insights From the Oncology Drug Development Experience.

Khakoo AY, Yurgin NR, Eisenberg PR, Fonarow GC.

JACC Basic Transl Sci. 2019 Apr 29;4(2):269-274. doi: 10.1016/j.jacbts.2019.01.011. eCollection 2019 Apr.

29.

Prevalence of Apparent Treatment-Resistant Hypertension in the United States According to the 2017 High Blood Pressure Guideline.

Patel KV, Li X, Kondamudi N, Vaduganathan M, Adams-Huet B, Fonarow GC, Vongpatanasin W, Pandey A.

Mayo Clin Proc. 2019 May;94(5):776-782. doi: 10.1016/j.mayocp.2018.12.033.

PMID:
31054605
30.

Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients With History of Stroke Plus Diabetes Mellitus.

Ehrlich ME, Liang L, Xu H, Kosinski AS, Hernandez AF, Schwamm LH, Smith EE, Fonarow GC, Bhatt DL, Peterson ED, Xian Y.

Stroke. 2019 Jun;50(6):1497-1503. doi: 10.1161/STROKEAHA.118.024172. Epub 2019 Apr 30.

PMID:
31035901
31.

Corrigendum to `Trends in Utilization of Surgical and Transcatheter Mitral Valve Repair in the United States☆' [The American Journal of Cardiology 123/7 (2019) 1187-1189].

Gupta T, Khera S, Kolte D, Goel K, Villablanca PA, Abbott JD, Fonarow GC, Rihal CS, Garcia MJ, Bhatt DL, Latib A, Weisz G.

Am J Cardiol. 2019 Jul 1;124(1):168. doi: 10.1016/j.amjcard.2019.04.001. Epub 2019 Apr 26. No abstract available.

PMID:
31030968
32.

Association of the New Peer Group-Stratified Method With the Reclassification of Penalty Status in the Hospital Readmission Reduction Program.

McCarthy CP, Vaduganathan M, Patel KV, Lalani HS, Ayers C, Bhatt DL, Januzzi JL Jr, de Lemos JA, Yancy C, Fonarow GC, Pandey A.

JAMA Netw Open. 2019 Apr 5;2(4):e192987. doi: 10.1001/jamanetworkopen.2019.2987.

33.

Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry.

Perino AC, Shrader P, Turakhia MP, Ansell JE, Gersh BJ, Fonarow GC, Go AS, Kaiser DW, Hylek EM, Kowey PR, Singer DE, Thomas L, Steinberg BA, Peterson ED, Piccini JP, Mahaffey KW.

J Am Heart Assoc. 2019 May 7;8(9):e011205. doi: 10.1161/JAHA.118.011205.

34.

Identifying a low-flow phenotype in heart failure with preserved ejection fraction: a secondary analysis of the RELAX trial.

Patel KV, Mauricio R, Grodin JL, Ayers C, Fonarow GC, Berry JD, Pandey A.

ESC Heart Fail. 2019 Aug;6(4):613-620. doi: 10.1002/ehf2.12431. Epub 2019 Apr 16.

35.

Prehospital statin use and low-density lipoprotein cholesterol levels at admission in acute coronary syndrome patients with history of myocardial infarction or revascularization: Findings from the Improving Care for Cardiovascular Disease in China (CCC) project.

Xing Y, Liu J, Hao Y, Liu J, Huo Y, Smith SC Jr, Ge J, Ma C, Han Y, Fonarow GC, Taubert KA, Morgan L, Yang N, Zhou M, Zhao D; CCC-ACS Investigators.

Am Heart J. 2019 Jun;212:120-128. doi: 10.1016/j.ahj.2019.02.019. Epub 2019 Mar 13.

PMID:
30986750
36.

Performance on management strategies with Class I Recommendation and A Level of Evidence among hospitalized patients with non-ST-segment elevation acute coronary syndrome in China: Findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) project.

Yang N, Liu J, Liu J, Hao Y, Huo Y, Smith SC Jr, Ge J, Ma C, Han Y, Fonarow GC, Taubert KA, Morgan L, Zhou M, Xing Y, Zhao D; CCC-ACS Investigators.

Am Heart J. 2019 Jun;212:80-90. doi: 10.1016/j.ahj.2019.02.012. Epub 2019 Mar 4.

PMID:
30981036
37.

Association of post-discharge specialty outpatient visits with readmissions and mortality in high-risk heart failure patients.

Edmonston DL, Wu J, Matsouaka RA, Yancy C, Heidenreich P, Piña IL, Hernandez A, Fonarow GC, DeVore AD.

Am Heart J. 2019 Jun;212:101-112. doi: 10.1016/j.ahj.2019.03.005. Epub 2019 Mar 21.

PMID:
30978555
38.

Home-time Is a Patient-Centered Outcome Variable for Stroke: An Executive Summary.

Shah S, Xian Y, Olson DM, Fonarow GC, Smith EE, Maisch L, O'Brien EC.

J Neurosci Nurs. 2019 Jun;51(3):110-112. doi: 10.1097/JNN.0000000000000437. No abstract available.

PMID:
30964840
39.

One- to 10-Day Versus 11- to 30-Day All-Cause Readmission and Mortality in Older Patients With Heart Failure.

Lam PH, Dooley DJ, Arundel C, Morgan CJ, Fonarow GC, Bhatt DL, Allman RM, Ahmed A.

Am J Cardiol. 2019 Jun 1;123(11):1840-1844. doi: 10.1016/j.amjcard.2019.03.007. Epub 2019 Mar 13.

PMID:
30928031
40.

Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation.

Madhavan M, Holmes DN, Piccini JP, Ansell JE, Fonarow GC, Hylek EM, Kowey PR, Mahaffey KW, Thomas L, Peterson ED, Chan P, Allen LA, Gersh BJ; ORBIT AF Investigators.

Am Heart J. 2019 May;211:77-89. doi: 10.1016/j.ahj.2019.01.005. Epub 2019 Jan 30.

PMID:
30901602
41.

Blood Pressure Control and Cardiovascular Outcomes in Patients With Atrial Fibrillation (From the ORBIT-AF Registry).

Vemulapalli S, Inohara T, Kim S, Thomas L, Piccini JP, Patel MR, Chang P, Fonarow GC, Ezekowitz MD, Hylek E, Go AS, Kowey PR, Mahaffey KW, Gersh BJ, Peterson ED.

Am J Cardiol. 2019 May 15;123(10):1628-1636. doi: 10.1016/j.amjcard.2019.02.010. Epub 2019 Feb 23.

PMID:
30846214
42.

Hospital Readmission Reduction Program for Heart Failure: The Spread of Intended and Unintended Consequences.

Fonarow GC, Ziaeian B.

J Am Coll Cardiol. 2019 Mar 12;73(9):1013-1015. doi: 10.1016/j.jacc.2018.12.043. No abstract available.

43.

Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction.

Greene SJ, Fonarow GC, DeVore AD, Sharma PP, Vaduganathan M, Albert NM, Duffy CI, Hill CL, McCague K, Patterson JH, Spertus JA, Thomas L, Williams FB, Hernandez AF, Butler J.

J Am Coll Cardiol. 2019 May 21;73(19):2365-2383. doi: 10.1016/j.jacc.2019.02.015. Epub 2019 Mar 4.

PMID:
30844480
44.

Medicare Shared Savings ACOs and Hospice Care for Ischemic Stroke Patients.

Kaufman BG, O'Brien EC, Stearns SC, Matsouaka RA, Holmes GM, Weinberger M, Schwamm LH, Smith EE, Fonarow GC, Xian Y, Taylor DH Jr.

J Am Geriatr Soc. 2019 Jul;67(7):1402-1409. doi: 10.1111/jgs.15852. Epub 2019 Mar 5.

PMID:
30835818
45.

When Payment Models Distort Perceptions and Care Delivery forPatients With Heart Failure.

Ziaeian B, Fonarow GC.

J Card Fail. 2019 Apr;25(4):227-229. doi: 10.1016/j.cardfail.2019.02.017. Epub 2019 Feb 26. No abstract available.

PMID:
30822510
46.

Do Women and Men Respond Similarly to Therapies in Contemporary Heart Failure Clinical Trials?

Vaduganathan M, Tahhan AS, Alrohaibani A, Greene SJ, Fonarow GC, Vardeny O, Lindenfeld J, Jessup M, Fiuzat M, O'Connor CM, Butler J.

JACC Heart Fail. 2019 Mar;7(3):267-271. doi: 10.1016/j.jchf.2018.12.016. Review. No abstract available.

PMID:
30819383
47.

Long-term outcomes for heart failure patients with and without diabetes: From the Get With The Guidelines-Heart Failure Registry.

Ziaeian B, Hernandez AF, DeVore AD, Wu J, Xu H, Heidenreich PA, Matsouaka RA, Bhatt DL, Yancy CW, Fonarow GC.

Am Heart J. 2019 May;211:1-10. doi: 10.1016/j.ahj.2019.01.006. Epub 2019 Jan 27.

PMID:
30818060
48.

In-Hospital Initiation of Angiotensin Receptor-Neprilysin Inhibitors-The Time Is Now.

Srivastava PK, Fonarow GC.

JAMA Cardiol. 2019 Mar 1;4(3):195-196. doi: 10.1001/jamacardio.2019.0104. No abstract available.

PMID:
30810709
49.

Derivation and external validation of a simple risk tool to predict 30-day hospital readmissions after transcatheter aortic valve replacement.

Khera S, Kolte D, Deo S, Kalra A, Gupta T, Abbott D, Kleiman N, Bhatt DL, Fonarow GC, Khalique OK, Kodali S, Leon MB, Elmariah S.

EuroIntervention. 2019 Jun 20;15(2):155-163. doi: 10.4244/EIJ-D-18-00954.

50.

Ultrafiltration versus diuretics for the treatment of fluid overload in patients with heart failure: a hospital cost analysis.

Costanzo MR, Fonarow GC, Rizzo JA.

J Med Econ. 2019 Jun;22(6):577-583. doi: 10.1080/13696998.2019.1584109. Epub 2019 Mar 21.

PMID:
30775944

Supplemental Content

Loading ...
Support Center